Biocon now holds approximately 98 per cent of the paid-up equity share capital of BBL on a fully diluted basis. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback